继发性白血病患者的18F-FDG PET/CT肝脏超扫描。

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2025-11-01 Epub Date: 2025-07-04 DOI:10.1097/RLU.0000000000005934

Ali Gümüş, Merve Nida Calderon Tobar, Gonca Kara Gedik

{"title":"继发性白血病患者的18F-FDG PET/CT肝脏超扫描。","authors":"Ali Gümüş, Merve Nida Calderon Tobar, Gonca Kara Gedik","doi":"10.1097/RLU.0000000000005934","DOIUrl":null,"url":null,"abstract":"Secondary leukemia can develop as a recognized side effect of chemotherapy and radiotherapy. In our case, an asymptomatic 61-year-old man was diagnosed with mixed-type Hodgkin lymphoma and underwent treatment with brentixumab-vedotin in 2021. Lately, the 18 F-FDG PET/CT scan we performed due to symptoms, revealed hepatomegaly and a diffusely increased FDG uptake in the liver. Following bone marrow biopsy revealed AML and the scan was consistent with hepatic superscan.","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"1035-1036"},"PeriodicalIF":9.6000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hepatic Superscan on 18 F-FDG PET/CT in a Patient With Secondary Leukemia.\",\"authors\":\"Ali Gümüş, Merve Nida Calderon Tobar, Gonca Kara Gedik\",\"doi\":\"10.1097/RLU.0000000000005934\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Secondary leukemia can develop as a recognized side effect of chemotherapy and radiotherapy. In our case, an asymptomatic 61-year-old man was diagnosed with mixed-type Hodgkin lymphoma and underwent treatment with brentixumab-vedotin in 2021. Lately, the 18 F-FDG PET/CT scan we performed due to symptoms, revealed hepatomegaly and a diffusely increased FDG uptake in the liver. Following bone marrow biopsy revealed AML and the scan was consistent with hepatic superscan.\",\"PeriodicalId\":10692,\"journal\":{\"name\":\"Clinical Nuclear Medicine\",\"volume\":\" \",\"pages\":\"1035-1036\"},\"PeriodicalIF\":9.6000,\"publicationDate\":\"2025-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Nuclear Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/RLU.0000000000005934\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/RLU.0000000000005934","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

摘要

继发性白血病可作为化疗和放疗的公认副作用而发展。在我们的病例中，一名无症状的61岁男性被诊断为混合型霍奇金淋巴瘤，并于2021年接受了brentixumab-vedotin治疗。最近，由于症状，我们进行了18F-FDG PET/CT扫描，显示肝脏肿大，肝脏弥漫性FDG摄取增加。骨髓活检显示急性髓性白血病，扫描与肝脏超扫相一致。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Hepatic Superscan on 18 F-FDG PET/CT in a Patient With Secondary Leukemia.

Secondary leukemia can develop as a recognized side effect of chemotherapy and radiotherapy. In our case, an asymptomatic 61-year-old man was diagnosed with mixed-type Hodgkin lymphoma and underwent treatment with brentixumab-vedotin in 2021. Lately, the 18 F-FDG PET/CT scan we performed due to symptoms, revealed hepatomegaly and a diffusely increased FDG uptake in the liver. Following bone marrow biopsy revealed AML and the scan was consistent with hepatic superscan.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.